260 results on '"Hammond, Milton L."'
Search Results
2. In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa
3. Discovery of betamethasone 17α-carbamates as dissociated glucocorticoid receptor modulators in the rat
4. Agonist-like SERM effects on ERα-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterus
5. Antagonist-Induced, Activation Function-2-Independent Estrogen Receptor α Phosphorylation
6. Ertapenem: a Group 1 carbapenem with distinct antibacterial and pharmacological properties
7. The fungal cell wall as a drug discovery target: SAR of novel echinocandin analogs
8. Chapter 13. Recent Advances in Anti-Infective Agents
9. Succinic Acids as Potent Inhibitors of Plasmid-borne IMP-1 Metallo-β-lactamase
10. Synthesis and SAR of thioester and thiol inhibitors of IMP-1 Metallo-β-Lactamase
11. Dicationic 2-fluorenonylcarbapenems: Potent anti-MRS agents with improved solubility and pharmacokinetic properties
12. Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®
13. SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitors
14. Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 2. N-Alkylated and open chain analogs of MK-8712
15. Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumannii
16. 2-(4-Carbonylphenyl)benzoxazole inhibitors of CETP: Scaffold design and advancement in HDLc-raising efficacy
17. 2-Arylbenzoxazoles as CETP inhibitors: Raising HDL-C in cynoCETP transgenic mice
18. 19-Hydroxy-IOS (19)-Dihydrovitamin D3 and 25-Hydroxy-24-norvitamin D3 : Analogs with Anti-Metabolite Activity and Related Studies
19. Discovery of pyrazolyl propionyl cyclohexenamide derivatives as full agonists for the high affinity niacin receptor GPR109A
20. Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 1. Discovery of a class C BLI for combination with imipinem
21. 2-Arylbenzoxazoles as CETP inhibitors: Substitution and modification of the α-alkoxyamide moiety
22. 2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety
23. Design of a novel class of biphenyl CETP inhibitors
24. Synthesis and biological evaluation of platensimycin analogs
25. Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A
26. Tetrahydro anthranilic acid as a surrogate for anthranilic acid: Application to the discovery of potent niacin receptor agonists
27. Biphenyl-Substituted Oxazolidinones as Cholesteryl Ester Transfer Protein Inhibitors: Modifications of the Oxazolidinone Ring Leading to the Discovery of Anacetrapib
28. Discovery of Substituted Biphenyl Oxazolidinone Inhibitors of Cholesteryl Ester Transfer Protein
29. Corrigendum to “2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety” [Bioorg. Med. Chem. Lett. 20 (2010) 346]
30. ChemInform Abstract: Antibacterial Activity of G6-Quaternary Ammonium Derivatives of a Lipophilic Vancomycin Analogue.
31. Discovery of a Biaryl Cyclohexene Carboxylic Acid (MK-6892): A Potent and Selective High Affinity Niacin Receptor Full Agonist with Reduced Flushing Profiles in Animals as a Preclinical Candidate
32. Discovery of Novel Tricyclic Full Agonists for the G-Protein-Coupled Niacin Receptor 109A with Minimized Flushing in Rats
33. Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A
34. Androstene-3,5-dienes as ER-β selective SERMs
35. Novel glucocorticoids containing a 6,5-bicyclic core fused to a pyrazole ring: Synthesis, in vitro profile, molecular modeling studies, and in vivo experiments
36. Bridged androstenediol analogs as ER-β selective SERMs
37. Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERα
38. Discovery of Biaryl Anthranilides as Full Agonists for the High Affinity Niacin Receptor
39. Erratum to “Triazolo-tetrahydrofluorenones as selective estrogen receptor beta agonists” [Bioorg. Med. Chem. Lett. 16 (2006) 4652–4656]
40. Tetrahydrofluorenones with conformationally restricted side chains as selective estrogen receptor beta ligands
41. Triazolo-tetrahydrofluorenones as selective estrogen receptor beta agonists
42. 6H-Benzo[c]chromen-6-one Derivatives as Selective ERβ Agonists.
43. Androstenediol analogs as ER-β-selective SERMs
44. Estrogen receptor ligands. Part 14: Application of novel antagonist side chains to existing platforms
45. Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain
46. Novel ketal ligands for the glucocorticoid receptor: in vitro and in vivo activity
47. Novel heterocyclic glucocorticoids: in vitro profile and in vivo efficacy
48. Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMs
49. In Vitro Bioactivation of Dihydrobenzoxathiin Selective Estrogen Receptor Modulators by Cytochrome P450 3A4 in Human Liver Microsomes: Formation of Reactive Iminium and Quinone Type Metabolites
50. Estrogen receptor ligands. Part 11: Synthesis and activity of isochromans and isothiochromans
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.